Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid-poly(lactide-co-glycolide) nanoparticles: From fabrication to preclinical validation

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 3, 2010, Pages 712-719

  Mondalek, Fadee G ^a,b   Ashley, Richard A ^b   Roth, Christopher C ^b   Kibar, Yusuf ^b   Shakir, Nabeel ^c   Ihnat, Michael A ^b   Fung, Kar Ming ^b,d   Grady, Brian P ^a   Kropp, Bradley P ^b   Lin, Hsueh Kung ^b,d  

^a University of Oklahoma   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Hyaluronic acid; PLGA nanoparticles; Small intestinal submucosa; Tissue regeneration

Indexed keywords

ANGIOGENESIS; HYALURONIC ACIDS; PLGA NANOPARTICLES; SMALL INTESTINAL SUBMUCOSA; TISSUE REGENERATION;

BIOCOMPATIBILITY; CELL PROLIFERATION; ENDOTHELIAL CELLS; NANOPARTICLES; ORGANIC ACIDS; ZETA POTENTIAL;

TISSUE;

HYALURONIC ACID POLY(LACTIDE CO GLYCOLIDE)NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DOG; MALE; NONHUMAN; PARTICLE SIZE; SWINE; SYNTHESIS; TISSUE REGENERATION; ZETA POTENTIAL;

ANIMALS; CHICK EMBRYO; DOGS; HUMANS; HYALURONIC ACID; INTESTINAL MUCOSA; INTESTINE, SMALL; LACTIC ACID; MALE; MATERIALS TESTING; NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYGLYCOLIC ACID; REGENERATION; SWINE; URINARY BLADDER;

EID: 77954805168     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32748     Document Type: Article

References (43)

1. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55:329-347. (Pubitemid 36297053)
2. Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 2006;17:247-289.
3. Cleek RL, Rege AA, Denner LA, Eskin SG, Mikos AG. Inhibition of smooth muscle cell growth in vitro by an antisense oligodeoxynucleotide released from poly(DL-lactic-co-glycolic acid) microparticles. J Biomed Mater Res 1997;35:525-530.
4. Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MN. Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Controlled Release 2007;119:77-85.
5. Vicari L, Musumeci T, Giannone I, Adamo L, Conticello C, De Maria R, Pignatello R, Puglisi G, Gulisano M. Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity. BMC Cancer 2008;8:212.
6. Shin HJ, Lee CH, Cho IH, Kim YJ, Lee YJ, Kim IA, Park KD, Yui N, Shin JW. Electrospun PLGA nanofiber scaffolds for articular cartilage reconstruction: Mechanical stability, degradation and cellular responses under mechanical stimulation in vitro. J Biomater Sci Polym Ed 2006;17:103-119.
7. Thapa A, Miller DC, Webster TJ, Haberstroh KM. Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials 2003;24:2915-2926.
8. Thapa A, Webster TJ, Haberstroh KM. Polymers with nano-dimensional surface features enhance bladder smooth muscle cell adhesion. J Biomed Mater Res A 2003;67:1374-1383. (Pubitemid 37522752)
9. Pattison MA, Wurster S, Webster TJ, Haberstroh KM. Three-dimensional, nano-structured PLGA scaffolds for bladder tissue replacement applications. Biomaterials 2005;26:2491-2500.
10. Jeon O, Rhie JW, Kwon IK, Kim JH, Kim BS, Lee SH. In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentiated osteogenically. Tissue Eng Part A 2008;14:1285-1294.
11. Laurent TC, Fraser JR. Hyaluronan. FASEB J 1992;6:2397-2404.
12. Bullard KM, Longaker MT, Lorenz HP. Fetal wound healing: Current biology. World J Surg 2003;27:54-61.
13. Mast BA, Frantz FW, Diegelmann RF, Krummel TM, Cohen IK. Hyaluronic acid degradation products induce neovascularization and fibroplasia in fetal rabbit wounds. Wound Repair Regen 1995;3: 66-72.
14. Nesti LJ, Li WJ, Shanti RM, Jiang YJ, Jackson W, Freedman BA, Kuklo TR, Giuliani JR, Tuan RS. Intervertebral disc tissue engineering using a novel hyaluronic acid-nanofibrous scaffold (HANFS) amalgam. Tissue Eng Part A 2008;14:1527-1537.
15. Ibrahim S, Ramamurthi A. Hyaluronic acid cues for functional endothelialization of vascular constructs. J Tissue Eng Regen Med 2008;2:22-32.
16. Suckow MA, Voytik-Harbin SL, Terril LA, Badylak SF. Enhanced bone regeneration using porcine small intestinal submucosa. J Invest Surg 1999;12:277-287.
17. Kim BS, Atala A, Yoo JJ. A collagen matrix derived from bladder can be used to engineer smooth muscle tissue. World J Urol 2008;26:307-314.
18. Matheny RG, Hutchison ML, Dryden PE, Hiles MD, Shaar CJ. Porcine small intestine submucosa as a pulmonary valve leaflet substitute. J Heart Valve Dis 2000;9:769-774.
19. Macleod TM, Sarathchandra P, Williams G, Sanders R, Green CJ. Evaluation of a porcine origin acellular dermal matrix and small intestinal submucosa as dermal replacements in preventing secondary skin graft contraction. Burns 2004;30:431-437.
20. Kropp BP, Rippy MK, Badylak SF, Adams MC, Keating MA, Rink RC, Thor KB. Regenerative urinary bladder augmentation using small intestinal submucosa: Urodynamic and histopathologic assessment in long-term canine bladder augmentations. J Urol 1996;155:2098-2104.
21. Shalhav AL, Elbahnasy AM, Bercowsky E, Kovacs G, Brewer A, Maxwell KL, Mcdougall EM, Clayman RV. Laparoscopic replacement of urinary tract segments using biodegradable materials in a large-animal model. J Endourol 1999;13:241-244.
22. Kropp BP, Cheng EY, Lin HK, Zhang Y. Reliable and reproducible bladder regeneration using unseeded distal small intestinal submucosa. J Urol 2004;172:1710-1713.
23. Hoeppner J, Crnogorac V, Marjanovic G, Juttner E, Karcz W, Weiser HF, Hopt UT. Small intestinal submucosa as a bioscaffold for tissue regeneration in defects of the colonic wall. J Gastrointest Surg 2009;13:113-119.
24. Raghavan D, Kropp BP, Lin HK, Zhang Y, Cowan R, Madihally SV. Physical characteristics of small intestinal submucosa scaffolds are location-dependent. J Biomed Mater Res A 2005;73:90-96. (Pubitemid 40354828)
25. Mondalek FG, Lawrence BJ, Kropp BP, Grady BP, Fung KM, Madihally SV, Lin HK. The incorporation of poly(lactic-co-glycolic) acid nanoparticles into porcine small intestinal submucosa biomaterials. Biomaterials 2008;29:1159-1166.
26. Yang Q, Titus M, Fung KM, Lin HK. 5α-Androstane-3α,17β- diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: Implication of androgen-independent prostate cancer progression. J Cell Biochem 2008;104:1612-1624.
27. Mondalek FG, Zhang YY, Kropp B, Kopke RD, Ge X, Jackson RL, Dormer KJ. The permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic field. J Nanobiotechnol 2006;4:4.
28. Badylak SF, Kropp B, Mcpherson T, Liang H, Snyder PW. Small intestinal submucosa: A rapidly resorbed bioscaffold for augmentation cystoplasty in a dog model. Tissue Eng 1998;4:379-387.
29. Fung KM, Samara EN, Wong C, Metwalli A, Krlin R, Bane B, Liu CZ, Yang JT, Pitha JV, Culkin DJ, Kropp BP, Penning TM, Lin HK. Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma. Endocr Relat Cancer 2006;13:169-180.
30. Hoang MV, Whelan MC, Senger DR. Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proc Natl Acad Sci USA 2004;101:1874-1879.
31. Storgard C, Mikolon D, Stupack DG. Angiogenesis assays in the chick CAM. Methods Mol Biol 2005;294:123-136.
32. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999;7:79-89.
33. Gao F, Cao M, Yang C, He Y, Liu Y. Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study. J Biomed Mater Res B Appl Biomater 2006;78:385-392.
34. Mohamed F, Van Der Walle CF. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci 2008;97:71-87.
35. Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 2003;20:212-220.
36. Hamann KJ, Dowling TL, Neeley SP, Grant JA, Leff AR. Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. J Immunol 1995;154:4073-4080.
37. Morra M. Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules 2005;6:1205-1223.
38. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985;228: 1324-1326. (Pubitemid 15000359)
39. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: An information-rich system. Eur J Cell Biol 2006;85:699-715.
40. Mast BA, Diegelmann RF, Krummel TM, Cohen IK. Hyaluronic acid modulates proliferation, collagen and protein synthesis of cultured fetal fibroblasts. Matrix 1993;13:441-446.
41. Cabrera RC, Siebert JW, Eidelman Y, Gold LI, Longaker MT, Garg HG. The in vivo effect of hyaluronan associated protein-collagen complex on wound repair. Biochem Mol Biol Int 1995;37: 151-158. (Pubitemid 26177887)
42. Olutoye OO, Barone EJ, Yager DR, Uchida T, Cohen IK, Diegelmann RF. Hyaluronic acid inhibits fetal platelet function: Implications in scarless healing. J Pediatr Surg 1997;32: 1037-1040.
43. Bauer SM, Bauer RJ, Velazquez OC. Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovascular Surg 2005;39:293-306.